Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Peptide Therapeutics Market: By Marketing Type: Generic, Branded; By Application: Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, Others; By Route of Administration; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Peptide Therapeutics Market Outlook

The global peptide therapeutics market stood at a value of around USD 33.58 billion in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 7.6% to reach USD 52.26 billion by 2027.

 

The Oral Segment to Hold a Significant Share in the Global Peptide Therapeutics Industry

The oral segment based on the route of administration is expected to account for a significant share in the market. The growing efforts by the drug developers to facilitate oral delivery of peptides due to the increased inclination of people towards minimally invasive treatments are likely to boost the segment growth.

 

Global Peptide Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Additionally, orally delivered peptide therapeutics facilitate patient compliance, diversify the treatment options, offer ease of administration, and boost marketability. These factors are likely to aid the market growth. Moreover, the expansion of the major biotechnology companies specialising in the oral delivery of peptides is anticipated to bolster the market growth in the forecast period.

 

North America Accounts for a Significant Share in the Market

The peptide therapeutics industry in North America is driven by factors such as the strong pharmaceutical and biopharmaceutical ecosystem in the region, easy access to medical facilities, and rapid growth in the development of therapeutic proteins. A considerable increase in the number of protein-based drugs, coupled with the increased investments to develop new therapeutic proteins for a wide range of ailments has supported the regional market expansion. In addition, the favourable government policies encouraging the sales of peptide-based drugs are anticipated to further aid the market growth in the region.

 

Peptide Therapeutics: Market Segmentation

Peptide therapeutics can be defined as peptide-based therapeutics used to treat various diseases. Peptide therapeutics mimic the functions of the naturally occurring peptides in the human body, further serving as a promising basis for targeting a range of diseases. They are often well tolerated by the body and have the potential for decreased off-target side effects.

Based on marketing type, the market has been segmented into:

  • Generic
  • Branded

The segmentation of the market based on application is as follows:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Cardiovascular
  • Others

On the basis of route of administration, the market is divided into:

  • Parenteral
  • Oral
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Cases of Chronic Diseases, coupled with the Increasing Prevalence of Cancer to Boost the Growth of the Peptide Therapeutics Industry

The rising cases of chronic diseases and the increasing prevalence of cancer are driving the global peptide therapeutics industry. Additionally, there has been a significant surge in the incidences of metabolic diseases such as diabetes among the geriatric population. Unhealthy and poor lifestyles led by people with hectic and busy schedules are likely to increase the risk of various kinds of diseases, thereby enhancing the therapeutic use of peptide drugs for different treatments. Hence, these factors are likely to provide impetus to the peptide therapeutics industry.  The complexity associated with large peptides is likely to restrain the market growth, however, the growing availability of biosimilars is expected to aid the market in the forecast period.

 

Key Industry Players in the Global Peptide Therapeutics Market

The report gives a detailed analysis of the following key players in the global peptide therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Pfizer Inc.
  • AstraZeneca PLC
  • GlaxoSmithKline PLC
  • Novartis AG
  • Amgen Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Marketing Type, Application, Route of Administration, Region
Breakup by Marketing Type Generic, Branded
Breakup by Application Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, Cardiovascular, Others
Breakup by Route of Administration Parenteral, Oral, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Amgen Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Peptide Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Peptide Therapeutics Historical Market (2018-2022) 
    8.3    Global Peptide Therapeutics Market Forecast (2023-2028)
    8.4    Global Peptide Therapeutics Market by Marketing Type
        8.4.1    Generic
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Branded
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Peptide Therapeutics Market by Application
        8.5.1    Gastrointestinal Disorders
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Neurological Disorders
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Metabolic Disorders
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Cancer
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Cardiovascular
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2018-2022)
            8.5.5.3    Forecast Trend (2023-2028)
        8.5.6    Others
    8.6    Global Peptide Therapeutics Market by Route of Administration
        8.6.1    Parenteral
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Oral
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Others
    8.7    Global Peptide Therapeutics Market by Region       
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022) 
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022) 
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022) 
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022) 
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022) 
            8.7.5.3    Forecast Trend (2023-2028)
9    North America Peptide Therapeutics Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Peptide Therapeutics Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Peptide Therapeutics Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Peptide Therapeutics Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Peptide Therapeutics Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Pfizer Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    AstraZeneca PLC
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3     GlaxoSmithKline PLC
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Novartis AG
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Amgen Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Peptide Therapeutics Market: Key Industry Highlights, 2018 and 2028
2.    Global Peptide Therapeutics Historical Market: Breakup by Marketing Type (USD Billion), 2018-2022
3.    Global Peptide Therapeutics Market Forecast: Breakup by Marketing Type (USD Billion), 2023-2028
4.    Global Peptide Therapeutics Historical Market: Breakup by Application (USD Billion), 2018-2022
5.    Global Peptide Therapeutics Market Forecast: Breakup by Application (USD Billion), 2023-2028
6.    Global Peptide Therapeutics Historical Market: Breakup by Route of Administration (USD Billion), 2018-2022
7.    Global Peptide Therapeutics Market Forecast: Breakup by Route of Administration (USD Billion), 2023-2028
8.    Global Peptide Therapeutics Historical Market: Breakup by Region (USD Billion), 2018-2022
9.    Global Peptide Therapeutics Market Forecast: Breakup by Region (USD Billion), 2023-2028
10.    North America Peptide Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
11.    North America Peptide Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
12.    Europe Peptide Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    Europe Peptide Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Asia Pacific Peptide Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Asia Pacific Peptide Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Latin America Peptide Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Latin America Peptide Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Middle East and Africa Peptide Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Middle East and Africa Peptide Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Global Peptide Therapeutics Market Structure

Key Questions Answered in the Report

In 2021, the global peptide therapeutics market attained a value of nearly USD 33.58 billion.

The market is estimated to grow at a CAGR of 7.6% between 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach USD 52.26 billion by 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising cases of chronic diseases such as cancer and tuberculosis, advancements in the field of medical science, and the growing healthcare spending, are expected to fuel the market growth.

The key market trends guiding the growth of the industry include the growing investments by the leading life sciences companies in research and development activities.

Generic and branded are the major marketing types considered within the market report.

Gastrointestinal disorders, neurological disorders, metabolic disorders, cancer, and cardiovascular, among others are the different applications of peptide therapeutics.

Parenteral, and oral, among others are the different routes of administration utilised in the industry.

The major players in the industry are Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Amgen Inc., among others.

Analyst Review

The global peptide therapeutics market attained a value of 33.58 billion in 2021, driven by the increasing prevalence of cancer. Aided by the increasing clinical trials and the growing FDA approval of biosimilars, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 7.6%. The market is projected to reach USD 52.26 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on marketing type, the market is divided into generic and branded. On the basis of application, the market is divided into gastrointestinal disorders, neurological disorders, metabolic disorders, cancer, and cardiovascular, among others. By route of administration, the market is divided into parenteral, and oral, among others. The major regional markets for peptide therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Amgen Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER